306 related articles for article (PubMed ID: 27993221)
1. Exendin-4, a glucagon-like peptide-1 analogue, accelerates diabetic wound healing.
Roan JN; Cheng HN; Young CC; Lee CJ; Yeh ML; Luo CY; Tsai YS; Lam CF
J Surg Res; 2017 Feb; 208():93-103. PubMed ID: 27993221
[TBL] [Abstract][Full Text] [Related]
2. Exendin-4, a glucagon-like peptide-1 analogue accelerates healing of chronic gastric ulcer in diabetic rats.
Chen YC; Ho CC; Yi CH; Liu XZ; Cheng TT; Lam CF
PLoS One; 2017; 12(11):e0187434. PubMed ID: 29095895
[TBL] [Abstract][Full Text] [Related]
3. The glucagon like peptide 1 analogue, exendin-4, attenuates oxidative stress-induced retinal cell death in early diabetic rats through promoting Sirt1 and Sirt3 expression.
Zeng Y; Yang K; Wang F; Zhou L; Hu Y; Tang M; Zhang S; Jin S; Zhang J; Wang J; Li W; Lu L; Xu GT
Exp Eye Res; 2016 Oct; 151():203-11. PubMed ID: 27212443
[TBL] [Abstract][Full Text] [Related]
4. Glucagon-like peptide-1 receptor agonist inhibits asymmetric dimethylarginine generation in the kidney of streptozotocin-induced diabetic rats by blocking advanced glycation end product-induced protein arginine methyltranferase-1 expression.
Ojima A; Ishibashi Y; Matsui T; Maeda S; Nishino Y; Takeuchi M; Fukami K; Yamagishi S
Am J Pathol; 2013 Jan; 182(1):132-41. PubMed ID: 23159951
[TBL] [Abstract][Full Text] [Related]
5. Combined Treatment with Bone Marrow-Derived Mesenchymal Stem Cells and Exendin-4 Promotes Islet Regeneration in Streptozotocin-Induced Diabetic Rats.
Song X; Sun X; Hao H; Han Q; Han W; Mu Y
Stem Cells Dev; 2021 May; 30(9):502-514. PubMed ID: 33677993
[TBL] [Abstract][Full Text] [Related]
6. The role of clusterin on pancreatic beta cell regeneration after exendin-4 treatment in neonatal streptozotocin administrated rats.
Kaya-Dagistanli F; Ozturk M
Acta Histochem; 2013 Jul; 115(6):577-86. PubMed ID: 23351716
[TBL] [Abstract][Full Text] [Related]
7. Exendin-4 in combination with adipose-derived stem cells promotes angiogenesis and improves diabetic wound healing.
Seo E; Lim JS; Jun JB; Choi W; Hong IS; Jun HS
J Transl Med; 2017 Feb; 15(1):35. PubMed ID: 28202074
[TBL] [Abstract][Full Text] [Related]
8. The major determinant of exendin-4/glucagon-like peptide 1 differential affinity at the rat glucagon-like peptide 1 receptor N-terminal domain is a hydrogen bond from SER-32 of exendin-4.
Mann RJ; Nasr NE; Sinfield JK; Paci E; Donnelly D
Br J Pharmacol; 2010 Aug; 160(8):1973-84. PubMed ID: 20649595
[TBL] [Abstract][Full Text] [Related]
9. Protection of exendin-4 analogue in early experimental diabetic retinopathy.
Zhang Y; Wang Q; Zhang J; Lei X; Xu GT; Ye W
Graefes Arch Clin Exp Ophthalmol; 2009 May; 247(5):699-706. PubMed ID: 19084986
[TBL] [Abstract][Full Text] [Related]
10. Beneficial effects of exendin-4 on experimental polyneuropathy in diabetic mice.
Himeno T; Kamiya H; Naruse K; Harada N; Ozaki N; Seino Y; Shibata T; Kondo M; Kato J; Okawa T; Fukami A; Hamada Y; Inagaki N; Seino Y; Drucker DJ; Oiso Y; Nakamura J
Diabetes; 2011 Sep; 60(9):2397-406. PubMed ID: 21810596
[TBL] [Abstract][Full Text] [Related]
11. Effects of exendin-4 and selenium on the expression of GLP-1R, IRS-1, and preproinsulin in the pancreas of diabetic rats.
Barakat G; Moustafa ME; Khalifeh I; Hodroj MH; Bikhazi A; Rizk S
J Physiol Biochem; 2016 Aug; 73(3):387-394. PubMed ID: 28589533
[TBL] [Abstract][Full Text] [Related]
12. Differences in the central anorectic effects of glucagon-like peptide-1 and exendin-4 in rats.
Barrera JG; D'Alessio DA; Drucker DJ; Woods SC; Seeley RJ
Diabetes; 2009 Dec; 58(12):2820-7. PubMed ID: 19741167
[TBL] [Abstract][Full Text] [Related]
13. Assessment of glucagon-like peptide-1 analogue and renin inhibitor on the binding and regulation of GLP-1 receptor in type 1 diabetic rat hearts.
Artinian SB; Al Lafi SM; Boutary SS; Bitar KM; Zwainy NS; Bikhazi AB
Exp Diabetes Res; 2011; 2011():489708. PubMed ID: 21747829
[TBL] [Abstract][Full Text] [Related]
14. Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes.
Kodera R; Shikata K; Kataoka HU; Takatsuka T; Miyamoto S; Sasaki M; Kajitani N; Nishishita S; Sarai K; Hirota D; Sato C; Ogawa D; Makino H
Diabetologia; 2011 Apr; 54(4):965-78. PubMed ID: 21253697
[TBL] [Abstract][Full Text] [Related]
15. Prolonged exendin-4 administration stimulates pituitary-adrenocortical axis of normal and streptozotocin-induced diabetic rats.
Malendowicz LK; Neri G; Nussdorfer GG; Nowak KW; Zyterska A; Ziolkowska A
Int J Mol Med; 2003 Oct; 12(4):593-6. PubMed ID: 12964040
[TBL] [Abstract][Full Text] [Related]
16. PEGylated exendin-4, a modified GLP-1 analog exhibits more potent cardioprotection than its unmodified parent molecule on a dose to dose basis in a murine model of myocardial infarction.
Sun Z; Tong G; Kim TH; Ma N; Niu G; Cao F; Chen X
Theranostics; 2015; 5(3):240-50. PubMed ID: 25553112
[TBL] [Abstract][Full Text] [Related]
17. Combination of omeprazole with GLP-1 agonist therapy improves insulin sensitivity and antioxidant activity in liver in type 1 diabetic mice.
Patel V; Joharapurkar A; Dhanesha N; Kshirsagar S; Detroja J; Patel K; Gandhi T; Patel K; Bahekar R; Jain M
Pharmacol Rep; 2013; 65(4):927-36. PubMed ID: 24145087
[TBL] [Abstract][Full Text] [Related]
18. Matrix- and plasma-derived peptides promote tissue-specific injury responses and wound healing in diabetic swine.
Sheets AR; Massey CJ; Cronk SM; Iafrati MD; Herman IM
J Transl Med; 2016 Jul; 14(1):197. PubMed ID: 27369317
[TBL] [Abstract][Full Text] [Related]
19. Effects of prolonged exendin-4 administration on entero-insular axis of normal and streptozotocin-induced diabetic rats.
Malendowicz LK; Macchi C; Nussdorfer GG; Nowak KW; Zyterska A; Ziolkowska A
Int J Mol Med; 2003 Jun; 11(6):763-6. PubMed ID: 12736719
[TBL] [Abstract][Full Text] [Related]
20. The pro-healing effect of exendin-4 on wounds produced by abrasion in normoglycemic mice.
Bacci S; Laurino A; Manni ME; Landucci E; Musilli C; De Siena G; Mocali A; Raimondi L
Eur J Pharmacol; 2015 Oct; 764():346-352. PubMed ID: 26164788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
